FDA
-
-
-
-
-
-
-
Pelthos Therapeutics acquires Xeglyze head lice treatment for $1.8 million
-
-
-
-
-
-
-
Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results
-
-
-
-
-
-
-
Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference
-
-
-
-
-
-
323,754 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

